Shares of Polydex Pharmaceuticals Ltd. (OTCMKTS:POLXF – Get Free Report) passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $1.99 and traded as low as $1.9860. Polydex Pharmaceuticals shares last traded at $1.9860, with a volume of 2,000 shares.
Polydex Pharmaceuticals Stock Performance
The company’s 50 day moving average price is $1.99 and its 200 day moving average price is $1.99.
Polydex Pharmaceuticals Company Profile
Polydex Pharmaceuticals Ltd. is a development stage company, which engages in manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, and the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market. The firm focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate and other specialty chemicals. The company was founded by Thomas C. Usher on June 14, 1979 and is headquartered in Toronto, Canada.
Further Reading
- Five stocks we like better than Polydex Pharmaceuticals
- 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks
- Why Wall Street Suddenly Sees SpaceX as an AI Company
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
